Jeffrey Paley - Net Worth and Insider Trading
Jeffrey Paley Net Worth
The estimated net worth of Jeffrey Paley is at least $258,462 dollars as of 2024-05-25. Jeffrey Paley is the Director of Journey Medical Corp and owns about 70,727 shares of Journey Medical Corp (DERM) stock worth over $254,617. Jeffrey Paley is also the Director of Avenue Therapeutics Inc and owns about 1,062 shares of Avenue Therapeutics Inc (ATXI) stock worth over $3,844. Details can be seen in Jeffrey Paley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey Paley has not made any transactions after 2023-11-28 and currently still holds the listed stock(s).
Transaction Summary of Jeffrey Paley
Jeffrey Paley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Paley owns 4 companies in total, including Avenue Therapeutics Inc (ATXI) , Immune Pharmaceuticals Inc (IMNPQ) , and Travere Therapeutics Inc (TVTX) among others .
Click here to see the complete history of Jeffrey Paley’s form 4 insider trades.
Insider Ownership Summary of Jeffrey Paley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATXI | Avenue Therapeutics Inc | 2018-12-10 | director |
| IMNPQ | Immune Pharmaceuticals Inc | 2017-01-25 | director |
| TVTX | Travere Therapeutics Inc | 2013-12-06 | director |
 | | 2023-11-28 | director |
Jeffrey Paley Latest Holdings Summary
Jeffrey Paley currently owns a total of 2 stocks. Among these stocks, Jeffrey Paley owns 70,727 shares of Journey Medical Corp (DERM) as of November 28, 2023, with a value of $254,617 and a weighting of 98.51%. Jeffrey Paley also owns 1,062 shares of Avenue Therapeutics Inc (ATXI) as of December 10, 2018, with a value of $3,844 and a weighting of 1.49%.
Latest Holdings of Jeffrey Paley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DERM | Journey Medical Corp | 2023-11-28 | 70,727 | 3.60 | 254,617 |
| ATXI | Avenue Therapeutics Inc | 2018-12-10 | 1,062 | 3.62 | 3,844 |
Holding Weightings of Jeffrey Paley
Jeffrey Paley Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey Paley has made a total of 4 transactions in Journey Medical Corp (DERM) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Journey Medical Corp is the sale of 1,745 shares on November 28, 2023, which brought Jeffrey Paley around $9,109.
According to the SEC Form 4 filings, Jeffrey Paley has made a total of 0 transactions in Avenue Therapeutics Inc (ATXI) over the past 5 years. The most-recent trade in Avenue Therapeutics Inc is the acquisition of 200 shares on December 10, 2018, which cost Jeffrey Paley around $78,600.
Insider Trading History of Jeffrey Paley
- 1
Jeffrey Paley Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey Paley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey Paley is 82.43%. GuruFocus also compares Jeffrey Paley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey Paley within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey Paley's insider trading performs compared to the benchmark.
Performance of Jeffrey Paley
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.2 | | | | | |
| Relative Return to S&P 500(%) | 11.09 | | | | | |
Jeffrey Paley Ownership Network
Jeffrey Paley Owned Company Details
What does Avenue Therapeutics Inc do?
Who are the key executives at Avenue Therapeutics Inc?
Jeffrey Paley is the director of Avenue Therapeutics Inc. Other key executives at Avenue Therapeutics Inc include 10 percent owner Fortress Biotech, Inc. , 10 percent owner Invagen Pharmaceuticals, Inc. , and Chief Executive Officer Alexandra Maclean .
Avenue Therapeutics Inc (ATXI) Insider Trades Summary
Over the past 18 months, Jeffrey Paley made no insider transaction in Avenue Therapeutics Inc (ATXI). Other recent insider transactions involving Avenue Therapeutics Inc (ATXI) include a net sale of 617,000 shares made by , a net purchase of 418,410 shares made by Fortress Biotech, Inc. , and a net purchase of 348,675 shares made by Rosenwald Lindsay A Md .
In summary, during the past 3 months, insiders sold 0 shares of Avenue Therapeutics Inc (ATXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,227 shares of Avenue Therapeutics Inc (ATXI) were sold and 10,228 shares were bought by its insiders, resulting in a net purchase of 2,001 shares.
Avenue Therapeutics Inc (ATXI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avenue Therapeutics Inc Insider Transactions
Jeffrey Paley Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey Paley. You might contact Jeffrey Paley via mailing address: C/o Retrophin Inc., 777 Third Avenue, 22nd Floor, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
